These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 19101123)
1. Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK. Enoch DA; Karas JA; Aliyu SH Int J Antimicrob Agents; 2009 Jun; 33(6):497-502. PubMed ID: 19101123 [TBL] [Abstract][Full Text] [Related]
2. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. Meddles-Torres C; Hu S; Jurgens C J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333 [TBL] [Abstract][Full Text] [Related]
3. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents. Zervos M Surg Infect (Larchmt); 2008; 9 Suppl 1():s29-34. PubMed ID: 18844472 [TBL] [Abstract][Full Text] [Related]
4. Invasive community-associated MRSA infections: epidemiology and antimicrobial management. Pichereau S; Rose WE Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116 [TBL] [Abstract][Full Text] [Related]
5. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Cunha BA Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085 [TBL] [Abstract][Full Text] [Related]
6. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. De Angelis G; Cipriani M; Cauda R; Tacconelli E Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490 [No Abstract] [Full Text] [Related]
7. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital. Esposito S; Leone S; Petta E; Noviello S; Ianniello F Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S30-5. PubMed ID: 19560673 [TBL] [Abstract][Full Text] [Related]
9. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. Teng CS; Lo WT; Wang SR; Tseng MH; Chu ML; Wang CC J Microbiol Immunol Infect; 2009 Aug; 42(4):324-8. PubMed ID: 19949756 [TBL] [Abstract][Full Text] [Related]
11. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related]
12. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Hyun DY; Mason EO; Forbes A; Kaplan SL Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459 [TBL] [Abstract][Full Text] [Related]
13. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center. Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235 [TBL] [Abstract][Full Text] [Related]
14. Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014. Klein EY; Mojica N; Jiang W; Cosgrove SE; Septimus E; Morgan DJ; Laxminarayan R Clin Infect Dis; 2017 Nov; 65(11):1921-1923. PubMed ID: 29020322 [TBL] [Abstract][Full Text] [Related]
15. Community acquired methicillin resistant Staphylococcus aureus hand infections: a South Pacific perspective - characteristics and implications for antibiotic coverage. Buchanan D; Heiss-Dunlop W; Mathy JA Hand Surg; 2012; 17(3):317-24. PubMed ID: 23061939 [TBL] [Abstract][Full Text] [Related]
16. Drugs for MRSA skin and soft-tissue infections. Med Lett Drugs Ther; 2014 May; 56(1442):39-40. PubMed ID: 24818839 [No Abstract] [Full Text] [Related]
17. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Ray GT; Suaya JA; Baxter R Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783 [TBL] [Abstract][Full Text] [Related]
18. Minocycline is a reliable and effective oral option to treat meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, including doxycycline treatment failures. Cunha BA Int J Antimicrob Agents; 2014 Apr; 43(4):386-7. PubMed ID: 24559866 [No Abstract] [Full Text] [Related]
19. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients. Trinh TT; Short WR; Mermel LA J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):176-80. PubMed ID: 19423878 [TBL] [Abstract][Full Text] [Related]
20. Minocycline for the treatment of community-acquired Staphylococcus aureus infections. Gelfand MS; Mazumder SA; Cleveland KO Int J Antimicrob Agents; 2014 Apr; 43(4):385-6. PubMed ID: 24613609 [No Abstract] [Full Text] [Related] [Next] [New Search]